Complement regulatory genes and hemolytic uremic syndromes.
about
Atypical hemolytic uremic syndromeRecurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipientVon Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpuraT-cell regulation by CD46 and its relevance in multiple sclerosisGenetic variants in the complement system predisposing to age-related macular degeneration: a reviewAlternative Complement Pathway Deregulation Is Correlated with Dengue SeverityMutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohortThe binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.The interaction between factor H and Von Willebrand factor.Inhibiting complement activation on cells at the step of C3 cleavage.Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure.Genetics and complement in atypical HUS.Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndromeAge-related penetrance of hereditary atypical hemolytic uremic syndrome.Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?Microparticle generation and leucocyte death in Shiga toxin-mediated HUS.Clinical grand rounds: atypical hemolytic uremic syndrome.Multifaceted hemolytic uremic syndrome in pediatrics.Assesment, treatment and prevention of atypical hemolytic uremic syndrome.Complement therapy in atypical haemolytic uraemic syndrome (aHUS).Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).Complement regulators in human disease: lessons from modern genetics.Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literatureReview: Complement and its regulatory proteins in kidney diseases.CD46-induced human Treg enhance B-cell responses.Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications.Complement control protein factor H: the good, the bad, and the inadequate.Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59.Defective complement inhibitory function predisposes to renal disease.Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kindRecent insights into the pathobiology of innate immune deficienciesComplement Dysregulation and Disease: Insights from Contemporary Genetics.Rare Variants in the Functional Domains of Complement Factor H Are Associated With Age-Related Macular Degeneration.Absence of CD59 exacerbates systemic autoimmunity in MRL/lpr mice.Transient removal of CD46 is safe and increases B-cell depletion by rituximab in CD46 transgenic mice and macaques.Heparan sulfate, including that in Bruch's membrane, inhibits the complement alternative pathway: implications for age-related macular degeneration.Discrimination between host and pathogens by the complement system.
P2860
Q21202864-982C4437-6AD5-4AC0-B928-D78C731CEE2EQ24601710-327B213F-25AE-42B7-BCA8-660C18C6ECCCQ24651320-26ECF541-7076-490F-A320-6E035CFF4D50Q24653362-B911291D-E5E4-40E9-98CD-E1F47885A7E1Q27021836-AB721658-1840-4838-B494-719C4E5BEA5BQ27489374-550193E5-21B7-4B91-81AD-4FFE991594BBQ28741729-50E1A985-DAF2-44D7-BE10-85ED3C108E60Q30377280-546282D1-E742-49C5-A50C-D8D1767FFD27Q31133820-EA71CF10-0B16-4D34-8F7B-6F7606F3163AQ33384196-C4CAC7CF-0937-46C7-B7A9-2EBBCB0B089FQ33385035-F92B4E51-3B45-4788-A3E0-63800748940FQ33385154-6B197385-AAA5-4A0D-92D1-47E9C1409C34Q33385329-0F12095F-BAC3-4D4F-962C-8329B220A95BQ33389945-7E8879FF-D615-4977-9C48-5C266B155177Q33391308-5CEB8AA0-FA2B-41CE-9578-1FED5BC97853Q33396792-9CF45E1C-2030-44DF-8B41-FA4FF125E2FEQ33397115-C443BAA1-C540-4E28-9B10-536575A8C88FQ33399052-749600BC-CE86-4122-B718-C6353E9C4A61Q33399130-92036B53-24CC-4C69-A3B3-314C2B6A68EBQ33400834-51AD6CC3-3340-4676-9A68-21588FCE7AE2Q33405452-9CC68585-7E92-43EA-864F-2CC931C0CB80Q33405916-5C4822A1-864D-46A2-B1DB-A690F990767DQ33408733-B9805D72-DEED-4850-986D-0F5B41EEC393Q33417246-8D2B9402-D1CB-49CB-90E1-3476144B7AA7Q33419261-8F294A97-E46A-4A69-9A5A-26D5C06B1FBCQ33421909-05678CBB-5AD4-4CEA-AE31-DC4F0CF2E3CAQ33647738-B3AA25E8-CF1B-4040-A1A1-048D3C73A091Q33796410-AAB251F8-F182-4D34-8496-8958011AD228Q33976312-4FA8FD24-1A2F-46E8-A308-DBDD15C3F3B3Q34067107-0A9E3633-59F1-49B6-A99B-F0EA6053A40AQ34173376-E237CA49-F194-4C9E-B397-C6EC49E9745EQ34465747-CFAB97AB-10F1-433C-844B-B5FDFB69C173Q35190461-7BA72983-5781-47BC-BFED-CF031AE922EAQ36125707-75D166B2-8F46-4CF9-9D25-0E2EEC41B82CQ36221928-970F5487-AE7C-4426-84BC-3BAFC36B1F36Q36228563-FEE543CA-B8AF-4C70-9C0D-50DAFF602899Q36426921-593D81A4-47C7-498F-B705-4EA162237D41Q36673736-2DFDA1DA-5BAF-49E2-96F8-E4B1158F2AC4Q36804333-1B2F6FF7-0B1C-4AC3-819E-08C8071C8A69Q37170042-42C99C9F-F826-40AA-B1D0-586A38F2E5C6
P2860
Complement regulatory genes and hemolytic uremic syndromes.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Complement regulatory genes and hemolytic uremic syndromes.
@ast
Complement regulatory genes and hemolytic uremic syndromes.
@en
type
label
Complement regulatory genes and hemolytic uremic syndromes.
@ast
Complement regulatory genes and hemolytic uremic syndromes.
@en
prefLabel
Complement regulatory genes and hemolytic uremic syndromes.
@ast
Complement regulatory genes and hemolytic uremic syndromes.
@en
P1476
Complement regulatory genes and hemolytic uremic syndromes.
@en
P2093
Anna Richards
John Atkinson
P304
P356
10.1146/ANNUREV.MED.59.060106.185110
P577
2008-01-01T00:00:00Z